As large proteins with different mechanisms might bypass the resistance pathways for small chemicals, TRAIL, with cytotoxicity in chemical-resistant cancer cells, has been considered as a novel therapeutic option for refractory cancers 30. This evidence concerns the gene TNFSF10 and cancer.